Intelligent Agent-Delivering Neural Probe Systems

This inventive concept integrates advanced technologies like AI, IoT, blockchain, and novel biomaterials with agent-delivering neural probes to create a more powerful system for neural stimulation and treatment.

Known neural probes have limitations in terms of damage to brain tissue, limited treatment agent delivery, and inadequate data tracking. This inventive concept addresses these limitations by incorporating synergistic technologies to enhance the functionality and efficacy of agent-delivering neural probes.

The inventive concept comprises a neural probe device with integrated AI-powered agent delivery systems, IoT-enabled sensors for real-time brain activity monitoring, blockchain-based secure data storage, and novel biomaterial coatings for enhanced agent delivery. The AI-powered system optimizes agent delivery based on patient-specific data, while the IoT-enabled sensor provides real-time feedback for personalized therapy. The blockchain-based data storage system ensures secure and transparent tracking of agent delivery and stimulation data.

The inventive concept's novelty lies in the synergistic integration of AI, IoT, blockchain, and novel biomaterials with agent-delivering neural probes, providing a more powerful system for neural stimulation and treatment. The inventive step is the combination of these distinct technologies to create a system that is more than the sum of its parts.

Alternative embodiments could include the use of different AI algorithms, IoT protocols, or blockchain platforms. Variations could include the integration of additional technologies, such as machine learning-based recommendation engines or cloud-based data analytics platforms.

The inventive concept has significant commercial potential in the fields of neurology, neuroscience, and medical technology, with potential applications in treating neurological disorders, such as epilepsy, Parkinson's disease, and chronic pain.